From the Department of Obstetrics and Gynecology, Women and Infants Hospital of Rhode Island, Providence, Rhode Island; the Department of Obstetrics and Gynecology, University of Washington, Seattle, Seattle, Washington; Department of Obstetrics and Gynecology, Oregon Health Sciences University, Portland, Oregon; the Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, San Francisco, California; and the Department of Reproductive Endocrinology and Infertility, Weill Cornell Medical College, New York, New York.
Obstet Gynecol. 2010 Dec;116(6):1387-1392. doi: 10.1097/AOG.0b013e3181fb8e59.
To compare the risk of gestational hypertension and preeclampsia in pregnancies conceived through standard in vitro fertilization (IVF) using autologous oocytes with pregnancies conceived using donated oocytes.
We conducted a retrospective, matched cohort study of women undergoing IVF using autologous compared with donor oocytes between 1998 and 2005. Women with live births resulting from oocyte donor pregnancies were matched for age and plurality (singleton or twin) with women undergoing autologous IVF. Primary outcomes were the incidence of preeclampsia or gestational hypertension (with and without proteinuria) in the third trimester. Data on preterm delivery, low birth weight, and embryo cryopreservation were also recorded.
Outcome data were available for 158 pregnancies, including 77 ovum-donor recipient pregnancies and 81 pregnancies using autologous oocytes. There were no differences in age, parity, and gestational type between the two cohorts. The incidence of gestational hypertension and preeclampsia was significantly higher in ovum-donor recipients compared with women undergoing autologous IVF (24.7% compared with 7.4%, P<.01, and 16.9% compared with 4.9%, P=.02, respectively). Ovum-donor recipients were more likely than women undergoing autologous IVF to deliver prematurely (34% compared with 19%). This association remained after controlling for multiple gestation (odds ratio 2.6, 95% confidence interval 1.04-6.3). Sixteen pregnancies from cryopreserved embryos were more likely to have hypertensive disorders of pregnancy (odds ratio 5.0, 95% confidence interval 1.2-20.5).
Pregnancies derived from donor oocytes and cryopreserved-thawed embryos may be at a higher risk for hypertensive disorders of pregnancy. These findings inform future research and help counsel women using assisted reproductive technology.
比较使用自体卵与捐赠卵进行体外受精(IVF)后妊娠发生妊娠期高血压和子痫前期的风险。
我们进行了一项回顾性、匹配队列研究,比较了 1998 年至 2005 年间使用自体卵与捐赠卵进行 IVF 的女性。卵母细胞捐赠妊娠的活产儿与接受自体 IVF 的女性按年龄和多胎(单胎或双胎)进行匹配。主要结局为第三孕期子痫前期或妊娠期高血压(有无蛋白尿)的发生率。还记录了早产、低出生体重和胚胎冷冻保存的数据。
共有 158 例妊娠结局数据,包括 77 例卵母细胞供体受者妊娠和 81 例使用自体卵的妊娠。两组在年龄、产次和妊娠类型方面无差异。与自体 IVF 相比,卵母细胞供体受者的妊娠期高血压和子痫前期发生率明显更高(24.7%比 7.4%,P<.01,16.9%比 4.9%,P=.02)。卵母细胞供体受者早产的可能性高于自体 IVF(34%比 19%)。在控制多胎后,这种关联仍然存在(比值比 2.6,95%置信区间 1.04-6.3)。来自冷冻胚胎的 16 例妊娠更有可能发生妊娠高血压疾病(比值比 5.0,95%置信区间 1.2-20.5)。
来源于供卵和冷冻-解冻胚胎的妊娠可能存在更高的妊娠高血压疾病风险。这些发现为未来的研究提供了信息,并帮助为使用辅助生殖技术的女性提供咨询。